Paper Details

  1. Home
  2. Paper Details

[New drugs for the treatment of constipation].

Author: AdamBirgit, GerkenGuido, LiebregtsTobias

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review discusses new therapeutic options for chronic idiopathic constipation and irritable bowel syndrome with constipation. It highlights prucalopride and lubiprostone, along with other promising medications currently under investigation. These new drugs offer alternatives for treating constipation after the withdrawal of tegaserod due to cardiac concerns.
Paper Details　
Original Abstract of the Article :
This review introduces new therapeutic options in the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation. Therefore, prucalopride and lubiprostone are discussed including their mechanisms and side effects. In addition, other substances that are currently unde...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s00063-010-1081-z

データ提供：米国国立医学図書館（NLM）

New Hope for Constipation: Introducing Prucalopride and Lubiprostone

This review explores the latest advancements in the treatment of [chronic idiopathic constipation] and [irritable bowel syndrome with constipation]. The authors focus on two new drugs, [prucalopride] and [lubiprostone], and discuss their [mechanisms of action], [efficacy], and [side effects]. They also highlight other promising treatments currently under evaluation, such as [renzapride] and [linaclotide].

The review highlights the importance of these new drugs in addressing the [challenges] of [constipation] treatment. It’s like finding a new source of water in a desert landscape - a welcome relief for those struggling with this condition. These drugs offer a [more effective and targeted] approach to [managing constipation], providing hope for [patients] seeking [relief] from this debilitating condition.

Finding Relief from Constipation: New Options on the Horizon

This review presents exciting new developments in the treatment of constipation. It’s like discovering a hidden oasis in the vast desert of constipation research - a source of hope and relief for those seeking a solution. The introduction of new drugs, such as prucalopride and lubiprostone, offers more targeted and effective treatment options for this common condition.

Easing the Burden of Constipation: Practical Tips for Daily Life

This review suggests that these new medications can significantly improve the lives of individuals with chronic idiopathic constipation and irritable bowel syndrome with constipation. It's like finding a comfortable resting spot in a harsh desert - a moment of respite from the struggle. These advancements in treatment offer hope for a more comfortable and fulfilling life.

Dr.Camel's Conclusion

This review highlights the exciting advancements in the treatment of constipation. The introduction of new drugs, such as prucalopride and lubiprostone, offers a more targeted and effective approach to managing constipation, providing hope for patients seeking relief from this debilitating condition. It’s like discovering a hidden oasis in the vast desert of constipation research - a source of hope and relief for those seeking a solution.

Date :
  1. Date Completed 2011-02-18
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

20676949

DOI: Digital Object Identifier

10.1007/s00063-010-1081-z

SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.